MPhil in Therapeutics Sciences at the University of Cambridge
Before the lockdown, a senior team from CHR, comprising of Matteo Perucchini (Partner), Chris Stevenson (CEO), Chris Reynolds (Principal), and Brendan Walkden (Principal) delivered an intensive 2 day workshop to the 18 students of the MPhil in Therapeutic Sciences at the University of Cambridge.
The 2 days were designed to provide students with both a background in the process of drug discovery and commercialization as well as the #commercial pressures which influence brand development and marketing strategies. The first day comprised of a lively debate concerning the successes and weaknesses of a high-profile drug launch, followed by sessions exploring how pharmaceutical companies develop and build brands through marketing tools and how they make strategic choices in the process.
With the theory completed, students were briefed on a wide-ranging case study which was designed to challenge their critical and strategic thinking within a framework of commercialization of therapies in the CAR-T space. Students were assigned into teams of 3 to compete for a team prize and the inaugural “CHR Strategic Thinking In Healthcare” award. The teams were given a week to prepare their case study presentations, task which was made more challenging by a number of breaking news, which tested their thinking and analysis.
The presentations by the students were of outstanding quality and showcased clear, evidence-based, strategic decision making and creativity with each group providing a highly engaging delivery.
Of the 6 teams however, the team comprised of Emma Norris, Harry Bickerstaffe, and Janvi Ahujawere were awarded the winning prize by the judging panel to round off a highly productive, enjoyable, and challenging workshop.